EFPIA latest statements and blogs – Read more
- Health after COVID-19: spend more but spend smarter (Nathalie Moll for the Parliament Magazine – 13.10.2020)
- COVID-19 vaccines: Why safety always comes first (Nathalie Moll for Euractiv – 17.09.2020)
- A new start for healthcare systems (Nathalie Moll for Euractiv – 08.09.2020)
- EFPIA statement on COVID-19 vaccine (26 August 2020)
- Make the regulatory system fit for the future of medical innovation (EFPIA Blog Article – 30.06.2020)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 22.06.2020)
- Preparing for a potential second COVID-19 wave (Joint statement by Medicines for Europe and EFPIA with A.T. Kearney – 22.06.2020)
- Time to step up investments in health systems: EFPIA statement on the EU4Health Programme (EFPIA Statement – 22.06.2020)
- COVID-19 and Brexit – Protecting patients across Europe from pandemics (EFPIA Statement – 19.06.2020)
- Joint Letter on the Need for a Mutual Recognition Agreement between the EU and UK (EFPIA Statement – 18.06.2020)
- United in the fight against COVID-19: EFPIA and Vaccines Europe response to the EU Strategy for COVID-19 vaccines (EFPIA Statement – 17.06.2020)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 08.06.2020)
- EU-level collaboration on joint clinical assessment of medicines in a post-COVID-19 world (EFPIA blog article – 08.06.2020)
- Building on the European Commission’s Roadmap for the EU Pharmaceutical Strategy (EFPIA Statement – 02.06.2020)
- The collaborative search for a COVID-19 vaccine (EFPIA blog article – 29.05.2020)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 18.05.2020)
- EFPIA statement following the call with EU Commissioner Kyriakides (EFPIA Statement – 18.05.2020)
- Resilience and recovery: EFPIA statement in advance of today’s meeting of EU Industry Ministers (EFPIA Statement – 15.05.2020)
- Cancer & COVID-19: a delicate balancing act – An interview with Antonella Cardone (EFPIA Bolog Article – 14.05.2020)
- Stories from the frontline: This is an ideal time to share knowledge and skills, especially when we have a common goal: stop the COVID-19 spreading (Guest blog) (EFPIA Blog Article – 14.05.2020)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 25.05.2020)
- EFPIA statement on the Corporate Europe Observatory Report on the Innovative Medicines Initiative (EFPIA Statement – 25.05.2020)
- YEAH project, the training opportunity to involve young people in health research (Guest blog – 20.05.2020)
- Clinical Trials: Servier adapts to ensure continuity (Guest blog – 20.05.2020)
- Going the extra mile to keep clinical trials on track during the COVID-19 pandemic (Guest blog – 20.05.2020)
- Shoulder to shoulder with patients with bladder cancer during times of pandemic (Guest blog – 25.05.2020)
- May is when we come together to help the world get more #BladderCancerAware (Guest blog – 25.05.2020)
- Bladder Cancer Awareness Month: reaffirming our commitment to people living with bladder cancer (Guest blog – 25.05.2020)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 18.05.2020)
- EFPIA statement following the call with EU Commissioner Kyriakides (EFPIA Statement – 18.05.2020)
- Resilience and recovery: EFPIA statement in advance of today’s meeting of EU Industry Ministers (EFPIA Statement – 15.05.2020)
- Cancer & COVID-19: a delicate balancing act – An interview with Antonella Cardone (EFPIA Bolog Article – 14.05.2020)
- Stories from the frontline: This is an ideal time to share knowledge and skills, especially when we have a common goal: stop the COVID-19 spreading (Guest blog) (EFPIA Blog Article – 14.05.2020)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 11.05.2020)
- Resilience and recovery: EFPIA statement in advance of tomorrow’s meeting of EU Health Ministers (EFPIA Statement – 08.05.2020)
- Europe’s COVID-19 battle: Data holds the key to ensuring patients get the medicines they need (EFPIA Statement – 08.05.2020)
- In-kind contributions to IMI projects (EFPIA Blog Article – 06.05.2020)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 27.04.2020)
- World IP Day – The shoulders of giants (EFPIA Bolog Article – 26.04.2020)
- EFPIA statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools (EFPIA Statement – 24.04.2020)
- Europe’s COVID-19 battle: Getting the data we need to ensure the supply of medicines (EFPIA News – 23.04.2020)
- The route out from under the cloud of coronavirus (EFPIA Statement – 23.04.2020)
- Europe’s fight against COVID-19: Seeing the best in people (EFPIA Bolog Article – 23.04.2020)
- Stories from the frontline: We must modestly make our contribution and stick together to express our spirit of solidarity (Guest blog) (EFPIA Bolog Article – 23.04.2020)
- Stories from the frontline: As an intensive care doctor, I could not wait and do nothing. It runs through my veins: I wanted to help (Guest blog) (EFPIA Bolog Article – 23.04.2020)
- Coronavirus – your questions answered (EFPIA News – 22.04.2020)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 21.04.20)
- COVID-19 and Cancer: Handling uncertainty – Working Together (Guest blog) (EFPIA Blog Article – 21.04.20)
- The COVID-19 “Regulatory Road to Innovation”: Lessons learned on optimising Research, Development and Regulatory Processes (EFPIA Blog Article – 21.04.20)
- Europe’s COVID-19 battle: Ensuring the supply of medicines and the continuity of clinical trials (EFPIA Statement – 19.04.20)
- Open letter to Members of the European Parliament in response to European Parliament resolution on EU coordinated action to combat the COVID-19 pandemic and its consequences (EFPIA open letter – 19.04.20)
- Solidarity, collaboration and partnership: EFPIA statement on the virtual meeting of EU Health Leaders (EFPIA Statement – 16.04.20)
- Creating the research eco-system in Europe to tackle COVID-19 and future pandemics (EFPIA statement in response to the publication of the EU’s ERAvsCorona action plan – 16.04.20)
- Partnership and collaboration: The new normal in the fight against COVID-19 (EFPIA Blog Article – 16.04.20)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 09.04.20)
- European Industry trade and supply chain needs to respond to Covid-19 (EFPIA Statements – 10.04.20)
- Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them (EFPIA Statement – 09.04.20)
- Managing ongoing Clinical Trials in the current COVID-19 pandemic situation (EFPIA Blog Article – 08.04.20)
- Official Update on the Connecting Healthcare Awards: A special COVID-19 category now available
- Indoors, but active and open more than ever to collaboration. From Italy, a story of ordinary civic commitment to protect health as a common good (Guest blog) (EFPIA Blog Article – 07.04.20)
- European pharmaceutical industry response to COVID-19 (EFPIA members Statements – Update 06.04.20)
- Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them (EFPIA Statement 03/04/20)
- COVID-19 – A multiplier impact on the diabetes community (Guest blog) (EFPIA Blog Article- 02/04/20)
- Trade policy and COVID-19: Openness and cooperation in times of a pandemic (EFPIA Blog Article- 02/04/20)
- European research-based industry publishes commitments on tackling COVID-19 (EFPIA Commitments – 01/04/20)
- Patient Organisations and Europe’s fight against COVID-19: Industry – let’s step up (EFPIA blog article: 30/03/20)
- Pharma volunteering during Covid-19 crisis (Guest blog) (EFPIA blog article: 30/03/20)
- Europe’s fight against COVID-19: EFPIA welcomes last night’s Statement of the Members of the European Council (EFPIA Statement: 27/03/20)
- #COVID19 and cancer (Guest blog) (EFPIA blog article: 26/03/20)
- COVID-19 – Fighting the fakes (EFPIA Statement: 25/03/20)
- Leadership at times of uncertainty (Guest blog) (EFPIA blog article: 24/03/20)
- Pharma boss: EU will have to focus on long-term medical research ecosystem (Euractiv: 23.03.20)
- Coronavirus – your questions answered (EFPIA Statement – 23.03.20)
- Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them (EFPIA Statement – 23.03.20)
- EFPIA update on research-based pharmaceutical industry response to COVID-19 (EFPIA web page on Covid-19 – last update 23.03.20)
- Europe’s COVID-19 battle: working together to ensure the supply of medicines to the patients that need them (EFPIA Statement – 18.03.20)
- Europe’s COVID-19 battle: supply, support and the search for diagnostics, vaccines, treatments and cures (EFPIA blog article – 18.03.20)
- Tackling COVID-19: EFPIA welcomes proactive and regular dialogue with Commissioners on the supply of medicines during the COVID-19 pandemic (EFPIA Statement – 13.03.20)
- European pharmaceutical industry response to COVID-19 (EFPIA Statement – 25.02.20)
- Joining the fight against coronavirus (EFPIA Statement – 04.02.20)
